US 12194016
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted A61KA61K31/27A61K31/325
Quick answer
US patent 12194016 (Methods of providing solriamfetol therapy to subjects with impaired renal function) held by AXSOME MALTA LTD. expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AXSOME MALTA LTD.
- Grant date
- Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/27, A61K31/325, A61K9/0053, A61P